Keyphrases
Fluorodeoxyglucose Uptake
100%
Newly Diagnosed Patients
100%
Locally Advanced Cervical Cancer
100%
Recurrent Disease
100%
Prognostic Biomarker
100%
Pelvic Lymph Nodes
100%
F-18 Fluorodeoxyglucose
100%
SUVmax
60%
Cervical Cancer
60%
Pelvic Disease
60%
Overall Survival
40%
Disease-specific Survival
40%
Treatment Response
20%
Positron Emission Tomography
20%
Cox Proportional Hazards Model
20%
Positron Emission Tomography-computed Tomography (PET-CT)
20%
Kaplan-Meier
20%
Standardized Uptake Value
20%
Obstetrics
20%
Cervical Tumor
20%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
20%
International Federations
20%
Prognostic Significance
20%
Stage IB
20%
Disease-specific
20%
Correlation Coefficient
20%
Age-stage
20%
Tumor Stage
20%
Fluorodeoxyglucose
20%
Recurrence Risk
20%
Pelvic Recurrence
20%
Pelvic Lymph Node Metastasis
20%
Cervical Cancer Patients
20%
Fluorodeoxyglucose Positron Emission Tomography/computed Tomography
20%
Persistent Disease
20%
Predicting Treatment Response
20%
Medicine and Dentistry
Biological Marker
100%
Pelvis
100%
Lymph Node
100%
Cervical Cancer
100%
Fluorodeoxyglucose F 18
100%
Fluorodeoxyglucose
42%
Recurrent Disease
42%
Pelvic Disease
42%
Treatment Response
28%
Positron Emission Tomography
28%
Overall Survival
28%
Disease Specific Survival
28%
Diseases
28%
Neoplasm
14%
Positron Emission Tomography-Computed Tomography
14%
Obstetrics
14%
Proportional Hazards Model
14%
Computer Assisted Tomography
14%
Lymph Node Metastasis
14%
Gynecology
14%
Standardized Uptake Value
14%
Recurrence Risk
14%
Cancer Staging
14%
Biochemistry, Genetics and Molecular Biology
Overall Survival
100%
Positron Emission Tomography
100%
Disease Specific Survival
100%
Computer Assisted Tomography
50%
Positron Emission Tomography-Computed Tomography
50%
Cancer Staging
50%